The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.882%)
Open: 17.50
High: 17.50
Low: 17.50
Prev. Close: 17.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Day

7 Feb 2019 07:00

RNS Number : 3048P
Thruvision Group PLC
07 February 2019
 

7 February 2019

Thruvision Group plc

 

Capital Markets Day

Thruvision Group plc (AIM: THRU), ("Thruvision" the "Company") the specialist provider of people-screening technology to the international security market, will host a Capital Markets Day for analysts and investors on 12 and 13 February 2019. The Group will be running similar sessions on both days, starting at 2.00pm GMT.

The event will be hosted by Colin Evans, Managing Director, and will include an update on recent progress, a technology demonstration and a tour of the Group's production facilities. No material new information will be provided, and the presentation will be available on Thruvision's website at:

 

www.thruvision.com/investors/

 

The sessions will be held at Thruvision's Milton Park headquarters: 121 Olympic Avenue, Milton Park, Abingdon, OX14 4SA. For more information, or to register your interest in attending one of the days, please contact:

 

joanna.garman@thruvision.com

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425 400

Tom Black, Executive Chairman

Colin Evans, Managing Director

 

Investec Bank plc +44 (0)20 7597 5970

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Harry Staight

 

 

 

 

About Thruvision

 

Thruvision Group plc is a specialist provider of people-screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing, at distances up to 10m. Addressing the growing need for fast, safe and effective security, Thruvision has been vetted and approved by the US Transportation Security Administration. More than 200 units have been deployed worldwide over the last five years for applications including mass transit and aviation security, facilities and public area protection, customs and border control and supply chain loss prevention. www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAXAKEDANEFF
Date   Source Headline
18th Jan 20187:00 amRNSAward of Share Options to Executive Directors
20th Dec 201710:48 amRNSDirector Dealing
15th Dec 20177:00 amRNSHalf-year Report
14th Dec 20177:00 amRNSAppointment of Finance Director
13th Dec 20177:00 amRNSNotice of Interim Results
12th Dec 20174:00 pmRNSDirector Dealing
27th Nov 201710:14 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirector Dealing
1st Nov 201711:12 amRNSChange of name from Digital Barriers PLC
31st Oct 20173:59 pmRNSCompletion of Disposal
26th Oct 201710:36 amRNSResult of General Meeting
23rd Oct 201710:49 amRNSResult of AGM
12th Oct 20177:00 amRNSProposed disposal: Increased Shareholder Support
9th Oct 20177:00 amRNSProposed disposal of the Video Business
2nd Oct 20173:15 pmRNSHolding(s) in Company
29th Sep 20174:54 pmRNSAnnual Report and Accounts
29th Sep 20177:00 amRNSFinal Results
7th Aug 20177:00 amRNS$11.9 million US Government Contract Award
12th Jul 20174:00 pmRNSChange of Registered Office
12th Jul 20173:30 pmRNSBrimtek deferred consideration
4th May 201711:33 amRNSHolding(s) in Company
2nd May 20177:01 amRNSInvestor Presentation
2nd May 20177:00 amRNSFramework Contract and Trading Update
21st Apr 201711:46 amRNSHolding(s) in Company
20th Apr 20177:00 amRNS$8.0 million US Government Contract Awards
13th Apr 20177:00 amRNSEuropean Framework Contract with G4S
11th Apr 20177:00 amRNSFacial recognition contract with Careem
4th Apr 20174:24 pmRNSHolding(s) in Company
4th Apr 20177:00 amRNSHolding(s) in Company
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 201711:08 amRNSSecond Price Monitoring Extn
24th Mar 201711:02 amRNSPrice Monitoring Extension
24th Mar 20177:00 amRNSTrading Update
15th Mar 201710:23 amRNSHolding(s) in Company
10th Mar 201712:26 pmRNSHolding(s) in Company
8th Mar 20175:13 pmRNSHolding(s) in Company
8th Mar 20172:00 pmRNSHolding(s) in Company
8th Mar 20171:58 pmRNSHolding(s) in Company
6th Jan 20177:00 amRNS$7.0m US and Africa Contract Awards
19th Dec 20167:00 amRNS$2.1m ThruVis Contract Award in Middle East
1st Dec 20167:00 amRNSContract wins across APAC and EMEA
29th Nov 20164:37 pmRNSPrice Monitoring Extension
29th Nov 20167:00 amRNSHalf-year Report
23rd Nov 20163:05 pmRNSHolding(s) in Company
1st Nov 20169:00 amRNSNotice of Results
18th Oct 20167:00 amRNSDigital Barriers agrees £10m credit facility
12th Oct 20167:00 amRNSTrading Update and US ThruVis Contract
10th Oct 20167:00 amRNSDigital Barriers and G4S technology partnership
23rd Sep 20162:51 pmRNSResult of AGM
20th Sep 20167:00 amRNSUS Contract Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.